BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Long J, Zhang S, Zeng X, Ouyang Y, Wang Y, Hu Z, Ye Y, Wu W, Jin F, Zhou S, Zeng Z. Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma. Front Mol Biosci 2020;7:586344. [PMID: 33330624 DOI: 10.3389/fmolb.2020.586344] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu S, Liu W, Ding Z, Yang X, Jiang Y, Wu Y, Liu Y, Wu J. Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma. Front Mol Biosci 2022;9:912620. [DOI: 10.3389/fmolb.2022.912620] [Reference Citation Analysis]
2 Qu T, Miao C, Zhang Z, Li H, Liu L, Lin W, Li C, Pan J, Ye L, Cao Y. Prognostic signature of endoplasmic reticulum stress-related long noncoding RNAs in head and neck squamous cell carcinoma: Association with somatic mutation and tumor immune microenvironment. Journal of Dental Sciences 2022. [DOI: 10.1016/j.jds.2022.09.005] [Reference Citation Analysis]
3 Beyaert S, Machiels JP, Schmitz S. Vaccine-Based Immunotherapy for Head and Neck Cancers. Cancers (Basel) 2021;13:6041. [PMID: 34885150 DOI: 10.3390/cancers13236041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
4 Feng B, Hess J. Immune-Related Mutational Landscape and Gene Signatures: Prognostic Value and Therapeutic Impact for Head and Neck Cancer. Cancers (Basel) 2021;13:1162. [PMID: 33800421 DOI: 10.3390/cancers13051162] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]